ES2081502T3 - Envolturas viricas artificiales. - Google Patents

Envolturas viricas artificiales.

Info

Publication number
ES2081502T3
ES2081502T3 ES91919952T ES91919952T ES2081502T3 ES 2081502 T3 ES2081502 T3 ES 2081502T3 ES 91919952 T ES91919952 T ES 91919952T ES 91919952 T ES91919952 T ES 91919952T ES 2081502 T3 ES2081502 T3 ES 2081502T3
Authority
ES
Spain
Prior art keywords
artificial viral
wraps
viral envelopes
production
artificial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91919952T
Other languages
English (en)
Inventor
Hans Schreier
Ramesh Chander
Arlene A Stecenko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Florida
Original Assignee
University of Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Florida filed Critical University of Florida
Application granted granted Critical
Publication of ES2081502T3 publication Critical patent/ES2081502T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Prostheses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE DESCUBRIO LA PRODUCCION DE ENVOLTURAS VIRICAS ARTIFICIALES MEDIANTE UNA NUEVA TECNICA DE DIALISIS POR "DOBLE DETERGENTE". ESTA ESPECIALMENTE ILUSTRADA LA PRODUCCION DE ENVOLTURAS VIRICAS DEL HIV-1 Y RSV. LAS RESULTANTES ENVOLTURAS VIRICAS ARTIFICIALES SON IDENTICAS A LAS DE VIRUS NATURALES, ESENCIALMENTE RESPECTO A LAS CARACTERISTICAS RELEVANTES PARA LA INMUNOGENETICA.
ES91919952T 1990-10-19 1991-10-17 Envolturas viricas artificiales. Expired - Lifetime ES2081502T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60064190A 1990-10-19 1990-10-19

Publications (1)

Publication Number Publication Date
ES2081502T3 true ES2081502T3 (es) 1996-03-16

Family

ID=24404456

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91919952T Expired - Lifetime ES2081502T3 (es) 1990-10-19 1991-10-17 Envolturas viricas artificiales.

Country Status (8)

Country Link
EP (1) EP0555333B1 (es)
JP (1) JP3414395B2 (es)
AT (1) ATE132034T1 (es)
DE (1) DE69115924T2 (es)
DK (1) DK0555333T3 (es)
ES (1) ES2081502T3 (es)
GR (1) GR3018918T3 (es)
WO (1) WO1992006677A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2369491C (en) 2000-02-02 2008-09-02 Yasufumi Kaneda Virus envelope vector for gene transfer
WO2002029410A2 (en) 2000-10-06 2002-04-11 Quantum Dot Corporation Cells having a spectral signature, and methods of preparation and use thereof
US20050059031A1 (en) 2000-10-06 2005-03-17 Quantum Dot Corporation Method for enhancing transport of semiconductor nanocrystals across biological membranes
EP1447080A1 (en) * 2003-02-13 2004-08-18 Bestewil Holding B.V. Method for producing virosome-like particles

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2650502C3 (de) * 1976-11-04 1980-01-17 Karl Dr.Med. 7302 Ostfildern Theurer Herstellung von Liposomen welche Arzneistoffe enthalten
DE3068743D1 (en) * 1980-01-16 1984-08-30 Weder Hans G Process and dialysis-installation for the preparation of bilayer-vesicles and their use
DE3173713D1 (en) * 1980-09-05 1986-03-20 Frappier Armand Inst Formation of an immunosome exclusively made of viral antigens reconstituted on an artificial membrane
LU86736A1 (fr) * 1987-01-15 1988-08-23 Univ Bruxelles Liposomes sensibilises a des molecules antigeniques de parasites intracellulaires,procede pour les preparations et leurs applications comme moyens de diagnostic et comme agents d'immunisation
IL86650A0 (en) * 1987-06-30 1988-11-30 Biophor Corp Animal derived cells and liposomes,having an antigenic protein incorporated into their membrane
AU626797B2 (en) * 1987-09-08 1992-08-13 Albany Medical College Immunogenic composites capable of selectively inducing antibody production, pharmaceutical compositions employing the same and method of selectively inducing antibody production

Also Published As

Publication number Publication date
EP0555333A1 (en) 1993-08-18
ATE132034T1 (de) 1996-01-15
DE69115924T2 (de) 1996-05-23
JP3414395B2 (ja) 2003-06-09
DK0555333T3 (da) 1996-04-29
JPH06502412A (ja) 1994-03-17
EP0555333B1 (en) 1995-12-27
WO1992006677A1 (en) 1992-04-30
GR3018918T3 (en) 1996-05-31
DE69115924D1 (de) 1996-02-08

Similar Documents

Publication Publication Date Title
DE69632256D1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
MX9205244A (es) Micelas modificadas de caseina.
ATE163197T1 (de) Albumin-derivate mit therapeutischer funktion
BR0116519B1 (pt) cartucho de hemodiafiltraÇço/hemofiltraÇço de diluiÇço intermediÁria.
ATE135743T1 (de) Monoklonale menschliche antikörper gegen hiv-i
EP0853662A4 (en) NEW REPLICABLE HUMAN IMMUNE WEAKNESS VIRUS TYPE II (HIV-2) PROVIRAL CLONE HIV-2KR
ES2081502T3 (es) Envolturas viricas artificiales.
ES2065019T3 (es) Un procedimiento de reduccion a pasta papelera que emplea celulasa.
FI901879A0 (fi) Foerfarande foer producering av naturligt hiv-gp160.
ES2072975T3 (es) Mezcla de esterilizante y metodo de esterilizacion.
AR218134A1 (es) Procedimiento para la preparacion de una solucion acuosa,esteril y estable,de cisplatina
BR9610932A (pt) Processo para armazenar microorganismos, composição de microorganismos e utilização da mesma
IT1209945B (it) Derivati piridinici e procedimenti per la loro preparazione
ES2174548T3 (es) Liposomas que contienen construcciones de peptidos con multiples ramificaciones para uso contra el virus de inmunodeficiencia humana.
FI881123A0 (fi) Inaktivering av human immunodeficiency virus (hiv) medelst fenol i proteinhaltiga loesningar.
ATE62599T1 (de) Verwendung einer loesung von alpha-chymotrypsin.
DK0516660T3 (da) Anvendelse af S-adenosylmethionin som middel mod virale infektioner med retrovira
ES2162123T3 (es) Dihidrato del (2r,3s)-3-terc.-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4-10beta-diacetoxi-2alfa-benzoiloxi-5beta,20-epoxi-1-hidroxi-9-oxo-19-nor-ciclopropa(g)tax-11-eno-13alfa-ilo y su procedimiento de preparacion.
CY1106318T1 (el) Χρηση ινωδων για την παρασκευη ενος φαρμακου χρησιμου στην θepαπεια της συμφορητικης καρδιακης ανεπαρκειας
DE68925191D1 (de) Peptide mit schutzeigenschaften gegen ein pathogenes virus des hiv-typs in sensitiven zellen
ITMI910220A1 (it) Peptidi sintetici atti a potenziare l'infettivita' del virus hiv-1
ES472072A1 (es) Procedimiento de preparacion del alfa-manoglicerido de 4(2- carboxifenilamino)-7-cloro-guinoleina.
FR2786488B1 (fr) Mutants de la gp120 et leurs applications biologiques
GR910100041A (el) Παράγωγα ουρίας, δρώντα σαν ζιζανιοκτόνα και μέ?οδος παρασκευής των.
RO98172B1 (ro) Proteza pentru sinus si procedeu de realizare

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 555333

Country of ref document: ES